CEO interview: Recent announcements and Q3 interim report

20 Nov 2023


Our CEO Sten R. Sörensen comments on the recent announcements and the Q3 interim report in an interview with BioStock. The interview is in Swedish.

Tune in to hear more about the secured financing and updates on the Phase II study of CS1 in rare disease PAH!

Watch here >